Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease
Overview
Authors
Affiliations
Von Hippel-Lindau (VHL) disease is a rare autosomal-dominant inherited tumor syndrome. We aimed to analyze the correlations between frequent mutations and phenotypes in Chinese VHL families. We screened 540 patients from 187 unrelated Chinese VHL families for 19 frequent VHL mutations. The penetrance and mean age at onset for VHL-associated susceptible organs were calculated and compared. The overall survival of VHL patients was described with Kaplan-Meier curves. Among the 19 frequent germline mutations, there were four hotspot mutation sites (194, 481, 499, and 500). Missense mutations were the most common types of mutations (70.0%) followed by nonsense mutations (20.0%) and splicing mutations (10.0%). Due to the diversity of these mutations, the penetrance for each organ and the age at onset are distinct. Even in cases of similar mutations, variance in the penetrance and age at onset was observed. The mean age at death for the patients in this cohort was 42.4 ± 13.5 years, and variability was observed in the Kaplan-Meier curves. We present a precise summary of the phenotypes for the frequent mutations in the largest Chinese VHL cohort, which provides valuable strategies for genetic counseling and clinical surveillance of VHL individuals.
Mori G, Fagundes G, Santana L, Freitas-Castro F, Afonso A, Lourenco Jr D Arch Endocrinol Metab. 2025; 69(1):e240354.
PMID: 39945572 PMC: 11834860. DOI: 10.20945/2359-4292-2024-0354.
Genetic insights and early monitoring: optimizing outcomes in pediatric renal cyst detection.
De Rosa L, Catania M, Sciarrone Alibrandi M Pediatr Nephrol. 2024; 40(2):597.
PMID: 39361134 DOI: 10.1007/s00467-024-06527-x.
Phenotypic and Genotypic Features of a Chinese Cohort with Retinal Hemangioblastoma.
Gao L, Zhang F, Hejtmancik J, Jiao X, Jia L, Peng X Genes (Basel). 2024; 15(9).
PMID: 39336783 PMC: 11431690. DOI: 10.3390/genes15091192.
Genetics, Pathophysiology, and Current Challenges in Von Hippel-Lindau Disease Therapeutics.
Gomez-Virgilio L, Velazquez-Paniagua M, Cuazozon-Ferrer L, Silva-Lucero M, Gutierrez-Malacara A, Padilla-Mendoza J Diagnostics (Basel). 2024; 14(17).
PMID: 39272694 PMC: 11393980. DOI: 10.3390/diagnostics14171909.
Azimi F, Naseripour M, Aghajani A, Kasraei H, Chaibakhsh S BMC Ophthalmol. 2024; 24(1):343.
PMID: 39138406 PMC: 11323439. DOI: 10.1186/s12886-024-03597-1.